Treatment outcome for metastatic papillary renal cell carcinoma patients.
about
Targeted therapies and the treatment of non-clear cell renal cell carcinomaExtreme hypothyroidism associated with sunitinib treatment for metastatic renal cancerA 20-year-old female with hemoptysis and high blood pressure: An unusual case of papillary renal cell carcinoma.Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.Expression of angiopoietin-1, 2 and 4 and Tie-1 and 2 in gastrointestinal stromal tumor, leiomyoma and schwannomaPD-L1 expression in papillary renal cell carcinomaThe impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysisRecent advances in the systemic treatment of metastatic papillary renal cancer.Racial difference in histologic subtype of renal cell carcinoma.Role of cytoreductive nephrectomy in renal cell carcinoma.Targeted therapy in renal cancer.Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature.Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.Pathology, therapy and prognosis of papillary renal carcinoma.A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study.A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma.Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinibThe impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.Occult infiltrating bi-ventricular papillary renal cell carcinoma metastasis found during coronary artery bypass graft surgery.Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report.An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples.
P2860
Q26995391-C9A9A344-E665-45F9-BFB3-7C13BB93607FQ33760079-34B3B657-3FC5-4B89-A17D-30E031F71913Q33773403-E3BEE111-4A3F-45D2-9B4C-F3056F0DC99CQ34206531-6F66A85B-C6B8-444A-8B9A-9CFB048DEDBCQ36179058-1DB8F23F-1160-4B86-987B-A566E0667347Q36249417-A01AA907-6BBC-4D93-806C-7EB8E7814820Q37010220-3A5F68A2-9ECF-44F4-8DC7-FEBEA53A50BCQ37411186-E794C0A4-8406-4450-8F13-4C6256FDA2C9Q37482609-36734173-6718-47A2-9E05-C7C98341BD79Q37575630-CE84A5E8-3D0E-4AFD-81A5-1D1DC4E2D87EQ37905587-47CAE895-9B19-4388-814A-9967EC358B05Q38071256-50E5FEF7-E939-4420-9EE5-3DD44C9EED04Q38081379-1C970AF1-2E35-4588-AB88-5FAFF760AE40Q38312048-F33D2A37-ADAE-4D0B-8129-50E1E316EAADQ38612642-ECD6578A-F08B-467B-B01B-CD0E1641F99DQ39505003-606DE2AE-8591-415F-8926-92815D150C22Q39532016-C5B7DBD6-5B31-4B1C-8C9E-3D957D4DA76FQ41313563-941902C4-CDD3-417B-A9DD-48F37445F021Q41827281-56BB3F65-D1CD-4AC3-A0B1-F7A76BF4B2F9Q41881548-E3AADADB-FA11-4D71-A6F4-7445EF27C02CQ41997465-73A57646-A1D5-4B62-A64F-ADEF42BE2654Q42158393-25ADE97D-B282-4B3D-B72D-2B87FC731A0FQ45026359-F2F36EE3-F40C-4158-9223-55C82C640C8B
P2860
Treatment outcome for metastatic papillary renal cell carcinoma patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Treatment outcome for metastatic papillary renal cell carcinoma patients.
@ast
Treatment outcome for metastatic papillary renal cell carcinoma patients.
@en
type
label
Treatment outcome for metastatic papillary renal cell carcinoma patients.
@ast
Treatment outcome for metastatic papillary renal cell carcinoma patients.
@en
prefLabel
Treatment outcome for metastatic papillary renal cell carcinoma patients.
@ast
Treatment outcome for metastatic papillary renal cell carcinoma patients.
@en
P2093
P356
P1433
P1476
Treatment outcome for metastatic papillary renal cell carcinoma patients.
@en
P2093
Ellen A Ronnen
G Varuni Kondagunta
Jennifer Bacik
Lesley Spodek
Nicole Ishill
Paul Russo
Victor Reuter
P304
P356
10.1002/CNCR.22340
P407
P577
2006-12-01T00:00:00Z